Focus and Scope

 Journal of Applied Biotechnology Reports (ISSN: 2322-1186) is the new presentation and publication resource for biotechnology researchers. The journal publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. It provides a medium for the rapid publication of full-length articles, short communications and technical reports on novel and innovative aspects of biotechnology. The journal of Applied Biotechnology Reports also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author's CV to the editorial office. The journal will have 4 issues per year that published concurrently in English and all officially accepted manuscripts will be immediately published online. The journal also encourages the submission of useful reports of negative results. 

The Submission and publication of papers in Journal of Applied Biotechnology Reports is free of charges.

Aim and Scope: The journal of Applied Biotechnology Reports publishes papers describing experimental work relating to all fundamental issues of biotechnology including:

Cell Biology, Genetics, Microbiology, Immunology, Molecular Biology, Biochemistry, Embryology,  Immunogenetics, Cell and Tissue Culture, Molecular Ecology, Genetic Engineering and Biological Engineering, Bioremediation and Biodegradation, Bioinformatics, Biotechnology Regulations, Pharmacogenomics, Gene Therapy, Plant, Animal, Microbial and Environmental Biotechnology, Nanobiotechnology, Medical Biotechnology, Biosafety, Biosecurity, Bioenergy, Biomass, Biomaterials and Biobased Chemicals and Enzymes.

Submitted manuscripts should present new results of original research or describe new theoretical or methodological approaches in biotechnology. Original experimental papers of pressing nature requiring rapid publication no longer than five typewritten pages, including figures, tables, and references, are published in the Short Communications section. The Journal will accept papers in all of biotechnology areas specially DNA/Protein engineering, all of Cell analysis fields (Genomics, Proteomics, Metabolomics, Systems biology etc.), Bioinformatics (Docking and Modeling), Imaging, Analytical biotechnology (Sensors/Detectors for Analytes/Macromolecules), Plant/Agricultural, Food, Microbial or Environmental biotechnology, Health and Therapeutical biotechnology (Including Antisense/siRNAs and PNAs, Enzymes, Peptides ...), Regenerative medicine (Stem cells, Tissue engineering and Biomaterials), Translational immunology (Antibody engineering, Xenotransplantation, T-Cell therapies), Medical biotechnology, Biosafety or Biosecurity.

Journal of Applied Biotechnology Reports promotes a special emphasis on

  • Improvement methods in biotechnology
  • Optimization process for high production in fermentor systems
  • Protein and enzyme engineering
  • Antibody engineering and monoclonal antibody
  • Molecular farming
  • Bioremediation
  • Immobilizing methods
  • biocatalysis

In particular, Journal of Applied Biotechnology Reports welcomes submissions on specific areas:

  • Metabolic Engineering: Metabolic engineering is the practice of optimizing genetic and regulatory processes within cells to increase the cells' production of a certain substance. These processes are chemical networks that use a series of biochemical reactions and enzymes that allow cells to convert raw materials into molecules necessary for the cell’s survival. Metabolic engineering specifically seeks to mathematically model these networks, calculate a yield of useful products, and pin point parts of the network that constrain the production of these products. Generally, genetic manipulation of species of interest to modify or allow the production of a commercially or therapeutically relevant compound.
  • Systems Biology and Bioinformatics: Overview and interplay between biological system components and their functional implications or focuses on complex interactions within biological systems (for example enzymes and metabolites in a metabolic pathway). Computational analysis of all topics mentioned below (modeling, algorithms, data deconvolution).
  • Nanobiotechnology and Biomaterials: Nanotechnology as defined by size is naturally very broad, including fields of science as diverse as surface science, organic chemistry, molecular biology, semiconductor physics, microfabrication, etc. Nanomaterials is a field that takes a materials science-based approach to nanotechnology that using for industrial biotechnology, drug delivery therapeutics, biochips, micro- and nanofluidics, nanosensors, and nanosystems for imaging; engineering materials for biological application, molecular imprinting, and biomimetics.
  • Medicine/ Red Biotechnology/ Stem cells: Red biotechnology refers to the use of organisms for the improvement of medical processes. It includes the designing of organisms to manufacture pharmaceutical products like antibiotics and vaccines, the engineering of genetic cures through genomic manipulation, and its use in forensics through DNA profiling, Therapeutic cloning (somatic cell nuclear transfer), tissue engineering, xenotransplantation; DNA or RNA therapeutics (gene therapy, targeting, immunogenicity); vaccines and applied immunology (Ab engineering, T-cell therapies, therapies exploiting innate immunity, antigen delivery vectors and approaches); Viral or non-viral strategies for drug delivery.
  • Synthetic Biology: is the design and construction of new biological devices (such as enzymes, genetic circuits, and cells or the redesign of existing biological systems) and systems for useful purposes. Synthetic biology builds on the advances in molecular, cell, and systems biology and seeks to transform biology in the same way that synthesis transformed chemistry and integrated circuit design transformed computing.
  • Mammalian Biotechnology/Genetics: Manipulating gene structure and control of gene expression; transgenic animals, knockouts, reproductive cloning, biopharmaceutical and enzyme production, transgene targeting and expression strategies. The development of mammalian cell biotechnology has led to an extensive range of commercially valuable prophylactic, diagnostic, and therapeutic compounds which can now be produced routinely by cell culture.
  • Industrial Biotechnology: is the application of biotechnology for industrial purposes, including manufacturing, alternative energy as bioenergy, and biomaterials. It includes the practice of using cells or components of cells like enzymes to generate industrially useful products by yeast or other organisms, use of enzymes as industrial catalysts, biopharmaceutics, biofuels.
  • Plant Biotechnology: Crop improvement (resistance to stress, disease, pests), nutraceuticals, forest biotech, plant vaccines or bioreactors, biosecurity and gene-containment strategies, bioenergy, microbial biodegradation, food biotech, environmental biotech: bioremediation, biomining, phytoremediation, monitoring.
  • Food Biotechnology: Application of microbiology and metabolic aspects to food and beverage systems; food safety and pathogens, food fermentation, food bioactive compounds.
  • Methods: Technical aspects and practical protocols for all biotech applications; Expression systems in mammalian, insect, bacterial, fungal or plant cells; Screening methods; Novel organism/cell/molecular imaging techniques, high throughput imaging tools for drug screening, fluorescence microscopy, electron microscopy/tomography, confocal imaging ... 

Publication Ethics and Malpractice Statement

 

Publication and authorship

  1. All submitted manuscripts to the JABR are subject to strict peer-review process by at least three reviewers that are experts in the area of applied biotechnology.
     
  2. The factors that are taken into account in review are relevance, soundness, significance, originality, readability and language.
     
  3. The possible decisions include acceptance, acceptance with revisions, or rejection.
     
  4. If authors are encouraged to revise and resubmit a submission, there is no guarantee that the revised submission will be accepted.
     
  5. Rejected manuscripts will not be re-reviewed.
     
  6. The manuscript acceptance is constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism.
     
  7. No research can be included in more than one publication.

 

Authors' responsibilities

  1. Authors must certify that their manuscripts are their original work.
  2. Authors must certify that the manuscript has not previously been published elsewhere.
     
  3. Authors must certify that the manuscript is not currently being considered for publication elsewhere.
     
  4. Authors must participate in the peer review process.
     
  5. Authors are obliged to provide retractions or corrections of mistakes.
     
  6. All Authors mentioned in the paper must have significantly contributed to the research.
     
  7. Authors must state that all data in the paper are real and authentic.
     
  8. Authors must notify the editors of any conflicts of interest.
     
  9. Authors must identify all sources used in the creation of their manuscript.
     
  10. Authors must report any errors they discover in their published paper to the editors.

 

Reviewers' responsibilities

  1. Reviewers should keep all information regarding papers confidential and treat them as privileged information.
     
  2. Reviews should be conducted objectively, with no personal criticism of the author
     
  3. Reviewers should express their views clearly with supporting arguments
     
  4. Reviewers should identify relevant published work that has not been cited by the authors.
     
  5. Reviewers should also call to the editor- in-chief's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
     
  6. Reviewers should not review manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

 

Editors' responsibilities

  1. Editors have complete responsibility and authority to reject/accept an article.
     
  2. Editors are responsible for the contents and overall quality of the publication.
     
  3. Editors should always consider the needs of the authors and the readers when attempting to improve the publication.
     
  4. Editors should guarantee the quality of the papers and the integrity of the academic record.
     
  5. Editors should publish errata pages or make corrections when needed.
     
  6. Editors should have a clear picture of a research's funding sources.
     
  7. Editors should base their decisions solely one the papers' importance, originality, clarity and relevance to publication's scope.
     
  8. Editors should not reverse their decisions nor overturn the ones of previous editors without serious reason.
     
  9. Editors should preserve the anonymity of reviewers.
     
  10. Editors should ensure that all research material they publish conforms to internationally accepted ethical guidelines.
     
  11. Editors should only accept a paper when reasonably certain.
     
  12. Editors should act if they suspect misconduct, whether a paper is published or unpublished, and make all reasonable attempts to persist in obtaining a resolution to the problem.
     
  13. Editors should not reject papers based on suspicions, they should have proof of misconduct.
     
  14. Editors should not allow any conflicts of interest between staff, authors, reviewers and board members.

Publishing Ethics Issues

  1. All editorial members, reviewers and authors must confirm and obey rules defined by COPE.
  2. Corresponding author is the main owner of the article so she/he can withdraw the article when it is incomplete (before entering the review process or when a revision is asked for).
  3. Authors cannot make major changes in the article after acceptance without a serious reason.
  4. All editorial members and authors must will to publish any kind of corrections honestly and completely.
  5. Any notes of plagiarism, fraudulent data or any other kinds of fraud must be reported completely to COPE.

 

 

Authors agreement form

 

Click for Download and Print

 

 

 

Indexing / Abstracting

 

 
Chemical Abstracts Service, CAS
 

Image result for ‫ارم نمایه جهان اسلام‬‎

          

 

     
     
     
   

        

          Research Bible

 

 
 

 

In Processing:

  • EMBASE
  • CINAHL
  • Ebsco
  • Biological Abstract
  • Current Content
  • CAB abstract
  • Asian Science Citation Index (ASCI)